首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1186501

HIV 診斷市場：當前分析和預測 (2022-2028)

HIV Diagnostics Market: Current Analysis and Forecast (2022-2028)

出版日期: 2022年11月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

在預測期內，全球 HIV 診斷市場規模預計將以約 9% 的顯著增長率增長。由於全球 HIV 流行率上升、獻血量增加以及政府和監管機構加大力度，預計全球 HIV 診斷市場將會增長。此外，快速的技術進步和越來越多的主要行業參與者專注於開發新的和先進的診斷測試並將其推向市場，這也在推動全球 HIV 診斷市場。

本報告審視了全球 HIV 診斷市場，並提供了包括 COVID-19 的影響、按細分市場劃分的市場洞察力、市場機會和趨勢以及主要參與者概況等信息。

內容

第一章市場介紹

第 2 章研究方法/假設

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對 HIV 診斷市場的影響

第 6 章 HIV 診斷市場收入（2020-2028 年）

第 7 章市場洞察：按測試類型

抗體檢測
病毒載量測試
CD4 測試
其他

第 8 章市場洞察：最終用戶

診斷實驗室
醫院
其他

第 9 章市場洞察：按地區

北美
- 美國
- 加拿大
- 其他
歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他
亞太地區
- 中國
- 日本
- 印度
- 其他
其他地區

第 10 章 HIV 診斷市場動態

市場驅動因素
市場挑戰
影響分析

第 11 章 HIV 診斷的市場機會

第 12 章 HIV 診斷的市場趨勢

第13章需求側與供給側分析

需求方分析
供應方分析

第14章價值鏈分析

第 15 章衝突場景

競爭格局
- 波特的五力分析

第十六章公司簡介

Siemens Healthineers
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Danaher Corporation
Becton, Dickinson & Company
Bio-Rad Laboratories
Thermo-Fisher Scientific Inc.
Merck KGaA
Hologic, Inc.
OraSure Technologies

第17章免責事項

簡介目錄

Product Code: UMME211307

Global HIV Diagnostics Market is expected to grow at a significant rate of around 9% during the forecast period. The global HIV Diagnostics market is anticipated to witness an uptick owing to the growing prevalence of HIV globally, rising number of blood donations, and increasing initiatives by government and regulatory bodies. For instance, the Egyptian government declared in 2020 that all 27 governorates in the nation would have access to free, confidential HIV diagnostic testing. Furthermore, the rapid technological advancement coupled with the growing focus of key industry players to develop and launch novel & advanced diagnostic tests in the market is also driving the HIV diagnostics market across the globe. For example, in 2020, Elecsys HIV Duo immunoassay was introduced in the United States by F. Hoffmann-La Roche AG following approval from the U.S. Food and Drug Administration (U.S. FDA) in April 2020. this is the first 4th generation HIV testing option in the United States that enables distinct detection of HIV p24 antigen and anti-HIV antibodies.

Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Becton, Dickinson & Company, Bio-Rad Laboratories, Thermo-Fisher Scientific Inc., Merck KGaA, Hologic, Inc., OraSure Technologies are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst test type, viral load test category to witness higher CAGR during the forecast period"

Based on the test type, the HIV diagnostics market is segmented into antibody tests, viral load tests, CD4 tests, and others. The viral load test segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to the increasing frequency of viral load testing in ART-treated HIV patients. Also, these tests improve the efficacy of treatment and produce better results in infected individuals which in turn is also contributing to the increased demand for this test.

"Amongst end-user, the diagnostic laboratories to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into diagnostic laboratories, hospitals, and others. The diagnostic laboratories segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period owing to the growing awareness of HIV/AIDS among the population globally. Also, rising investments, growing advancement in technology and the presence of advanced diagnostics tools in these laboratories are also some of the factors driving the market of this segment.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the HIV Diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure and the rising incidences of HIV owing to the lack of preventive techniques adopted by people in the region. For instance, In 2019, the estimated number of HIV infections in the U.S. was 34,800 and the rate was 12.6 (per 100,000 people). Furthermore, an increase in government initiatives and an increasing awareness among the population are also driving the market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global HIV diagnostics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the HIV Diagnostics Market
2.2. Research Methodology of the HIV Diagnostics Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HIV DIAGNOSTICS MARKET

6 HIV DIAGNOSTICS MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TEST TYPE

7.1. Antibody Tests
7.2. Viral Load Tests
7.3. CD4 Tests
7.4. Others

8 MARKET INSIGHTS BY END-USER

8.1. Diagnostic Laboratories
8.2. Hospitals
8.3. Others

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World